SCHEMBL3845849

SCHEMBL3845849

CNC(=O)c1ccc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cn23)s1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 3/20 0.42
HPGD P15428 2/20 0.42
FLT3 P36888 5/20 0.42
TGFBR1 P36897 5/20 0.40
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ATM Q13315 1/20 0.36
CSNK1D P48730 2/20 0.36
CSNK1E P49674 2/20 0.36
MKNK1 Q9BUB5 2/20 0.34
FYN P06241 1/20 0.34
STIM1 Q13586 1/20 0.34
ORAI1 Q96D31 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846603 0.90 FLT3 (0.41) FLT3TGFBR1
SCHEMBL5853404 0.89 FLT3 (0.42) RAB9AALDH1A1NPC1FLT3TGFBR1
SCHEMBL3845853 0.85 FLT3 (0.36) KDM4ERAB9AALDH1A1NPC1HPGD
SCHEMBL3848398 0.83 FLT3 (0.44) FLT3TGFBR1
SCHEMBL3848105 0.83 FLT3 (0.44) FLT3TGFBR1
SCHEMBL3845544 0.83 FLT3 (0.44) FLT3TGFBR1MKNK1MKNK2
SCHEMBL3848179 0.82 FLT3 (0.45) FLT3TGFBR1CSNK1DCSNK1EFYN
Hydrochloric Acid SCHEMBL3852301 0.80 KDM4E (0.47) KDM4ERAB9AALDH1A1NPC1HPGD
SCHEMBL3846088 0.80 FLT3 (0.45) RAB9ANPC1FLT3MEN1MAPT
SCHEMBL3845550 0.80 FLT3 (0.41) KDM4ERAB9AALDH1A1FLT3TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed